Why Pharma Should be Focusing on ESG
Die Inhalte dieser Seite sind leider nicht auf Deutsch verfügbar.
mit Google übersetzenReport | May 2, 2022
The concept of sustainability has evolved over time and is no longer solely focused on harmful emissions into the atmosphere. Today, it is an umbrella term for environmental, social, and governance (ESG) issues.
Read Datwyler’s white paper on “Why Pharma Should be Focusing on ESG” to learn more about how the pharma industry is taking charge to improve these critical issues.
